Company Biodel Inc Nasdaq
Equities
US09064M1053
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
2023 | CAC40: in green, gains over 2% on a weekly basis | CF |
2023 | CAC40: PMI and ISM data point to 22nd week of gains | CF |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 60 | 03-12-07 | |
President | 57 | 23-03-01 | |
Joan Connolly
CTO | Chief Tech/Sci/R&D Officer | - | 21-04-12 |
Paul Streck
CTO | Chief Tech/Sci/R&D Officer | 60 | 22-12-18 |
Heather White
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-01 |
Alan Sokaler
BRD | Director/Board Member | - | - |
Corporate Secretary | - | 23-03-01 | |
Michelle Graham
HRO | Human Resources Officer | 57 | 19-11-03 |
Muffy Carter
LAW | General Counsel | 71 | 16-11-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 55 | 23-03-01 | |
Director/Board Member | 62 | 23-03-01 | |
Alan Sokaler
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 20,709,043 | 18,650,831 ( 90.06 %) | 7,760 ( 0.0375 %) | 90.06 % |
Company contact information
Albireo Pharma, Inc.
53 State Street 19th Floor
02109, Boston
+857 254 5555
![address Biodel Inc](https://cdn.zonebourse.com/static/address/50256.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- ALBO Stock
- Stock
- Company Biodel Inc